Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.

Abstract:

:The aim of the present study was to evaluate the performance of whole-body diffusion-weighted imaging (WB-DWI), whole-body positron emission tomography with computed tomography (WB-PET/CT), and whole-body positron emission tomography with magnetic resonance imaging (WB-PET/MRI) in staging patients with untreated invasive ductal carcinoma of the breast. Fifty-one women with newly diagnosed invasive ductal carcinoma of the breast underwent WB-DWI, WB-PET/CT and WB-PET/MRI before treatment. A radiologist and a nuclear medicine physician reviewed in consensus the images from the three modalities and searched for occurrence, number and location of metastases. Final staging, according to each technique, was compared. Pathology and imaging follow-up were used as the reference. WB-DWI, WB-PET/CT and WB-PET/MRI correctly and concordantly staged 33/51 patients: stage IIA in 7 patients, stage IIB in 8 patients, stage IIIC in 4 patients and stage IV in 14 patients. WB-DWI, WB-PET/CT and WB-PET/MRI incorrectly and concordantly staged 1/51 patient as stage IV instead of IIIA. Discordant staging was reported in 17/51 patients. WB-PET/MRI resulted in improved staging when compared to WB-PET/CT (50 correctly staged on WB-PET/MRI vs. 38 correctly staged on WB-PET/CT; McNemar's test; p<0.01). Comparing the performance of WB-PET/MRI and WB-DWI (43 correct) did not reveal a statistically significant difference (McNemar test, p=0.14). WB-PET/MRI is more accurate in the initial staging of breast cancer than WB-DWI and WB-PET/CT, however, the discrepancies between WB-PET/MRI and WB-DWI were not statistically significant. When available, WB-PET/MRI should be considered for staging patient with invasive ductal breast carcinoma.

journal_name

Int J Oncol

authors

Catalano OA,Daye D,Signore A,Iannace C,Vangel M,Luongo A,Catalano M,Filomena M,Mansi L,Soricelli A,Salvatore M,Fuin N,Catana C,Mahmood U,Rosen BR

doi

10.3892/ijo.2017.4012

subject

Has Abstract

pub_date

2017-07-01 00:00:00

pages

281-288

issue

1

eissn

1019-6439

issn

1791-2423

journal_volume

51

pub_type

杂志文章
  • A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.

    abstract::Effects of vorozole, a potent and specific non-steroidal aromatase inhibitor, were evaluated on female Sprague-Dawley (SD) rats with 7, 12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors. Vorozole at a dose of 0.25, 1.0 and 4.0 mg/kg was orally administered once a day for 28 consecutive days. A significant reg...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Sugamata N,Koibuchi Y,Iino Y,Morishita Y

    更新日期:1999-02-01 00:00:00

  • Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells.

    abstract::Chemotherapeutic treatment with combinations of drugs is front-line therapy for many types of cancer. Combining drugs that target different signaling pathways often lessens adverse side-effects while increasing the efficacy of treatment and reducing patient morbidity. Histone deacetylase (HDAC) inhibitors represent a ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Sato T,Suzuki M,Sato Y,Echigo S,Rikiishi H

    更新日期:2006-05-01 00:00:00

  • In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.

    abstract::The aim of the present work is to investigate whether microtubule-affecting drugs including vincristine, vinblastine, vindesine and vinorelbine are able to produce an anti-angiogenic effect at non-cytotoxic doses in the same way of taxol. The cytotoxic effects were determined by means of the colorimetric MTT assay, an...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Hayot C,Farinelle S,De Decker R,Decaestecker C,Darro F,Kiss R,Van Damme M

    更新日期:2002-08-01 00:00:00

  • Production and characterization of a monoclonal antibody (MSN-3) for uterine endometrial and endocervical adenocarcinoma.

    abstract::A monoclonal antibody (MSN-3) was raised using HEC-108 cells derived from poorly differentiated endometrial carcinoma as the immunogen. The immunoglobulin subclass of MSN-3 was IgGr1. The target antigen of MSN-3 was a protein with a molecular weight of 77 kDa, and it was shown to be localized in the cytoplasm. MSN-3 o...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.4.749

    authors: Hasegawa K,Tsukazaki K,Kubushiro K,Kobayashi Y,Kobiki K,Udagawa Y,Nozawa S

    更新日期:1997-10-01 00:00:00

  • Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.

    abstract::Lymph node metastasis of tumors is a crucial early step in the metastatic process. Tumor lymphangiogenesis plays an important role in promoting tumor metastasis to regional lymph nodes. Norcantharidin (NCTD) has been reported to possess potent anti-angiogenesis and antitumor propert...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1603

    authors: Liu ZY,Qiu HO,Yuan XJ,Ni YY,Sun JJ,Jing W,Fan YZ

    更新日期:2012-11-01 00:00:00

  • Inhibition of autocrine fibroblast growth factor signaling by the adenovirus-mediated expression of an antisense transgene or a dominant negative receptor in human glioma cells in vitro.

    abstract::Autocrine fibroblast growth factor (FGF) signaling was genetically manipulated in human gliomas by an adenovirus-mediated strategy. Antisense inhibition of endogenous basic FGF (bFGF) expression showed inhibition of the proliferation of human glioma cells (U251MG, NMC-G1) without promoting apoptosis. The reduction in ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Aoki T,Kato S,Fox JC,Okamoto K,Sakata K,Morimatsu M,Shigemori M

    更新日期:2002-09-01 00:00:00

  • [Corrigendum] The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.

    abstract::Subsequent to the publication of the above article, the authors have realized that there were errors associated with Figs. 1c and 2b. In Fig. 1c, the authors noted that the same data were incorrectly presented for the 'Untreated cells" and 'DMSO' dot‑blot experiments. After having re‑examined their source data, the au...

    journal_title:International journal of oncology

    pub_type: 杂志文章,已发布勘误

    doi:10.3892/ijo.2019.4874

    authors: Nestal De Moraes G,Pereira Castro C,Salustiano EJ,Dumas ML,Costas F,Wing-Fai Lam E,Ribeiro Costa PR,Maia RC

    更新日期:2019-12-01 00:00:00

  • Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro.

    abstract::Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present st...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4488

    authors: Schröterová L,Ježková A,Rudolf E,Caltová K,Králová V,Hanušová V

    更新日期:2018-10-01 00:00:00

  • DPC 4/SMAD 4 in non-pancreatic tumors with frequent LOH 18q21 and in hematological malignancies.

    abstract::Recently, a novel candidate tumor suppressor gene, DPC 4/SMAD 4, has been implicated in the development of pancreatic cancers. Its location at human chromosome 18q21 prompted us to investigate this gene in a large series of primary tumors located outside the gastrointestinal tract which have been associated with loss ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Verbeek W,Spirin K,Hatta Y,Miller C,Kawamata N,Takeuchi S,Koike M,Asou H,Simpson J,Koeffler H

    更新日期:1997-02-01 00:00:00

  • Immunomodulation by adriamycin - effect on the production of cytotoxic and inflammatory antitumor immune-responses.

    abstract::We have recently demonstrated in a mouse renal adenocarcinoma tumor system that the antitumor effect of adriamycin (ADM) in combination with interleukin-2 (IL2) is superior to treatment with either ADM or IL2 alone. Based on this observation we postulated that modulation of host's immune competence by ADM and/or IL2 m...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Gautam S,Chikkala N,Ganapathi R

    更新日期:1992-12-01 00:00:00

  • Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients.

    abstract::Thymidylate synthase (TS) is known to have polymorphisms in the 5' and 3' untranslated region (UTR). These polymorphisms have been reported to be associated with high TS expression and chemoresistance to 5-FU. The aim of this study was to examine the prognostic roles of the 5'-UTR and 3'-UTR TS polymorphisms in esopha...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Kuramochi H,Tanaka K,Oh D,Lehman BJ,Dunst CM,Yang DY,De Meester SR,Hagen JA,Danenberg KD,De Meester TR,Danenberg PV

    更新日期:2008-01-01 00:00:00

  • Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.

    abstract::A multi-kinase inhibitor, sorafenib, was recently approved and is currently recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, HCC treatment outcomes are still poor and necessitate improvement. Therefore, we investigated the influence of sorafenib in ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1676

    authors: Nojiri K,Sugimoto K,Shiraki K,Tameda M,Inagaki Y,Ogura S,Kasai C,Kusagawa S,Yoneda M,Yamamoto N,Takei Y,Nobori T,Ito M

    更新日期:2013-01-01 00:00:00

  • Determination of telomerase activity in squamous cell carcinoma of the penis.

    abstract::Telomerase activity was studied in 51 penile carcinomas, and detected in all samples from 3 patients with verrucous carcinoma, in 85.4% (41/48) of invasive carcinomas, in 81.8% (9/11) of adjacent non-cancerous skin and in 80% (8/10) of adjacent non-cancerous corpus cavernosum. All skin and corpus cavernosum samples fr...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.18.1.67

    authors: Alves G,Fiedler W,Guenther E,Nascimento P,Campos MM,Ornellas AA

    更新日期:2001-01-01 00:00:00

  • Decreased expression of the SPOP gene is associated with poor prognosis in glioma.

    abstract::This study suggests that speckle-type POZ protein (SPOP) may be a tumor suppressor gene and its prognostic value in human glioma. Real-time quantitative RT-PCR (qRT‑PCR), western blotting, and immunohistochemical staining were used to examine SPOP expression in glioma tissues and normal brain (NB) tissues. The relatio...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2729

    authors: Ding D,Song T,Jun W,Tan Z,Fang J

    更新日期:2015-01-01 00:00:00

  • MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.

    abstract::Mammalian sterile-20-like kinase 4 (MST4) has been implicated in cell proliferation and differentiation. In a previous study, we found MST4 to be an important candidate gene for metastatic hepatocellular carcinoma (HCC); however, the molecular mechanism of the promoting role of MST4 in HCC metastasis is poorly underst...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2455

    authors: Lin ZH,Wang L,Zhang JB,Liu Y,Li XQ,Guo L,Zhang B,Zhu WW,Ye QH

    更新日期:2014-08-01 00:00:00

  • Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.

    abstract::In the multistep progressive pathogenesis of human breast cancer, comedo ductal carcinoma in situ (DCIS) represents a preinvasive precursor lesion for therapy resistant invasive cancer. Human tissue derived cell culture models exhibiting molecular similarities to clinical DCIS facilitate an important preclinical mecha...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Katdare M,Osborne M,Telang NT

    更新日期:2002-10-01 00:00:00

  • Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells.

    abstract::Multi-drug resistance (MDR) limits the effectiveness of chemotherapy. P-glycoprotein encoded by the MDR1 gene, is known to be implicated in MDR phenotype, but other factors could be determinant in MDR. The aim of this study was to investigate new molecular factors potentially associated with the MDR phenotype using a ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Visentin M,Simula MP,Sartor F,Petrucco A,De Re V,Toffoli G

    更新日期:2009-05-01 00:00:00

  • Extracts of Bridelia ovata and Croton oblongifolius induce apoptosis in human MDA‑MB‑231 breast cancer cells via oxidative stress and mitochondrial pathways.

    abstract::Breast cancer is the most common type of cancer and is also the second leading cause of cancer‑associated death in women worldwide. Thus, there is an urgent requirement for the development of effective treatments for this disease. Bridelia ovata and Croton oblongifolius are herbs used in Thai traditional medicine that...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.4973

    authors: Poofery J,Sripanidkulchai B,Banjerdpongchai R

    更新日期:2020-04-01 00:00:00

  • The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells.

    abstract::177Lu‑DOTATATE was recently approved for the treatment of somatostatin receptor (SSTR)‑positive neuroendocrine tumors (NETs). However, despite impressive response rates, complete responses are rare. Heat shock protein 90 (HSP90) inhibitors have been suggested as suitable therapeutic agents for NETs, as well as a poten...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4888

    authors: Lundsten S,Spiegelberg D,Stenerlöw B,Nestor M

    更新日期:2019-12-01 00:00:00

  • Preoperative radiotherapy for muscle-invading bladder-carcinoma.

    abstract::One hundred five patients with clinical stage T2-T4 transitional cell bladder carcinoma who completed either low-dose (20-26 Gy) or high dose (40-50 Gy) preoperative radiotherapy (RT) followed by cystectomy were reviewed. Five-year actuarial survival was 42%, 52%, and 17% for stages T2, T3, and T4, respectively. Five-...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.1.5.555

    authors: Cox J,Greven K,Anscher M,Morgan T

    更新日期:1992-10-01 00:00:00

  • Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression.

    abstract::An endocrine disrupting chemical (EDC) is a global health concern. In this study, we examined the effects of genistein (GEN) on bisphenol A (BPA) or 17β-estradiol (E2)-induced cell growth and gene alterations of BG-1 ovarian cancer cells expressing estrogen receptors (ERs). In an in...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1719

    authors: Hwang KA,Kang NH,Yi BR,Lee HR,Park MA,Choi KC

    更新日期:2013-02-01 00:00:00

  • Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families.

    abstract::Seventy French high-risk families were screened for germ-line BRCA-1 mutations. The BRCA-1 coding region and the exon-intron boundaries were sequenced, except when pre-screening by PTT revealed a truncated protein in exon 11. Germ-line BRCA-1 mutations were detected in 24% of families. The number of breast and ovarian...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.14.5.971

    authors: Laplace-Marieze V,Presneau N,Sylvain V,Kwiatkowski F,Lortholary A,Hardouin A,Bignon YJ

    更新日期:1999-05-01 00:00:00

  • Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome.

    abstract::Induction chemotherapy provides an excellent model for evaluation of potential predictive factors. We studied expression of SBR grade, estrogen (ER) and progesterone (PR) receptors, HER2, Ki67 and P53 on core biopsies before and after chemotherapy in a series of 115 patients, who received anthracycline-based induction...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Penault-Llorca F,Cayre A,Bouchet Mishellany F,Amat S,Feillel V,Le Bouedec G,Ferrière JP,De Latour M,Chollet P

    更新日期:2003-06-01 00:00:00

  • Impact of carbamylation and glycation of collagen type I on migration of HT1080 human fibrosarcoma cells.

    abstract::Collagen type I is an abundant component of the extracellular matrix and due to its longevity, constitutes a prominent target of non-enzymatic post-translational in vivo modifications such as carbamylation and glycation. These protein modifications involved in aging, renal diseases and diabetes, are linked to elevated...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1393

    authors: Said G,Guilbert M,Millerot-Serrurot E,Van Gulick L,Terryn C,Garnotel R,Jeannesson P

    更新日期:2012-06-01 00:00:00

  • Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.

    abstract::Overexpression of TMPRSS4, a cell surface-associated transmembrane serine protease, has been reported in pancreatic, colorectal and thyroid cancers, and has been implicated in tumor cell migration and metastasis. Few reports have investigated both TMPRSS4 gene expression levels and ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1513

    authors: Nguyen TH,Weber W,Havari E,Connors T,Bagley RG,McLaren R,Nambiar PR,Madden SL,Teicher BA,Roberts B,Kaplan J,Shankara S

    更新日期:2012-09-01 00:00:00

  • Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model.

    abstract::Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to induce apoptosis in a variety of cancer cells, including colon, prostate, breast and leukemia. Among them, aspirin, a classical NSAID, shows promise in cancer therapy in certain types of cancers. We hypothesized that aspirin...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1304

    authors: Hossain MA,Kim DH,Jang JY,Kang YJ,Yoon JH,Moon JO,Chung HY,Kim GY,Choi YH,Copple BL,Kim ND

    更新日期:2012-04-01 00:00:00

  • Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccines.

    abstract::Cancer cells genetically modified to secrete immunoregulatory cytokines offer great promise for human cancer treatment as tumor vaccines. However, in preclinical animal studies, large established cancer burdens have appeared difficult to eradicate with such vaccines. For example, lethally-irradiated GM-CSF-secreting C...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.1.161

    authors: Nigam A,Yacavone RF,Zahurak ML,Johns CM,Pardoll DM,Piantadosi S,Levitsky HI,Nelson WG

    更新日期:1998-01-01 00:00:00

  • The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma.

    abstract::The poor prognosis of Ewing's sarcoma (EWS), together with its high lethal recurrence rate and the side‑effects of current treatments, call for novel targeted therapies with greater curative effectiveness and substantially reduced side‑effects. The oncogenic chimeric protein EWS/FLI1 is the key malignancy driver in mo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.2016

    authors: Sengupta A,Rahman M,Mateo-Lozano S,Tirado OM,Notario V

    更新日期:2013-09-01 00:00:00

  • Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway.

    abstract::Fluoroquinolone antibiotics induce cytotoxicity in various cancer cell lines and may therefore represent a potentially important source of novel anticancer agents. The aim of the present study was to examine the effect of ciprofloxacin on the viability, redox balance, apoptosis, expression of p53, Bax and Bcl-2, cell ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4310

    authors: Beberok A,Wrześniok D,Rok J,Rzepka Z,Respondek M,Buszman E

    更新日期:2018-05-01 00:00:00

  • DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.

    abstract::We investigated the expression and promoter methylation of dbpA in human hepatocellular carcinoma (HCC) and examined their correlation with clinicopathological features. In 96 paired samples of HCC and adjacent non-tumorous liver, and 10 normal liver specimens, dbpA mRNA was quantif...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1282

    authors: Yasen M,Obulhasim G,Kajino K,Mogushi K,Mizushima H,Tanaka S,Tanaka H,Hino O,Arii S

    更新日期:2012-03-01 00:00:00